Zhongshan Latterson Biotechnology Co., Ltd.

Other Hot-Sale Products (Raw Powder)

» Other Hot-Sale Products (Raw Powder)

Pharmaceutical Grade Antiemetic Powder Granisetron Hydrochloride Powder 107007-99-8

CATEGORY AND TAGS:
Other Hot-Sale Products (Raw Powder)
Model Number : 107007-99-8
Certification : ISO9001 , GMP , KOSHER , SGS
Place of Origin : China
MOQ : 10g
Price : Negotiable ( Discounts For Big Order )
Payment Terms : Western Union , Moneygram , Bitcoin , Bank Transfer
Supply Ability : 100kg per month
Delivery Time : 7 work days
Packaging Details : Stealth And Discreet Packaging
Product Name : Granisetron hydrochloride
CAS : 107007-99-8
MF : C18H25ClN4O
MW : 348.87
EINECS : 1312995-182-4
Color : White to Off-White Crystalline Sold
enquiry
  • Specifications

Granisetron Hydrochloride CAS: 107007-99-8

Superiority

Zhongshan Latterson Biotechnology Co., Ltd., is a comprehensive pharmaceutical enterprise, which specialized in bio-pharmaceutical technology over 7 years. The company is located in Zhongshan City, Guangdong Province , China.
Our factory covers an area of 33500 square meters, with clean environment and nice layout. There are several large or medium workshops and QA and research center with advanced equipment. At present, our main products are Anabolic Steroid series, Peptide series, Local Anesthetic series. Our products reach the advanced standard of domestic market, many of which reach the international standard, certificates contain: KOSHER , ISO 9001:2008 , GMP , SGS.

Quick Details:

Product Name Granisetron hydrochloride
Synonyms 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxamid;endo-1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxa;endo-monohydrochlorid;midehydrochloride;1-METHYL-N-[(3-ENDO)-9-METHYL-9-AZABICYCLO[3.3.1]NON-3-YL]-1H-INDAZOLE-3-CARBOXAMIDE HYDROCHLORIDE;KYTRIL;BRL-43694A;GRANISERTROL HYDROCHLORIDE
CAS No. 107007-99-8
Molecular Formula C18H25ClN4O
Molecular Weight 348.87
EINECS No. 1312995-182-4
Melting point 290-292°C
Boiling point 532ºC at 760mmHg
Solubility H2O: >10mg/mL
Flash point 275.6ºC
Steam pressure 0mmHg at 25°C
Refractive index 1.69
Appearance White Powder
Purity 99%
Quality Standard USP
Storage Conditions Room temp
Packing 1kg/foil bag;25kg/drum
Shipment EMS;DHL;FedEx;TNT;UPS
Delivery Time 3-5 Working Days
Payment terms T/T;Western Union;Money Gram;Bitcoin
Usage For nausea and vomiting caused by radiotherapy, cytotoxic chemotherapy

Descriptions:

Granisetron hydrochloride was originally developed by Beecham in the UK in the mid-1980s. In 1991, the combined Smithkline-Beecham (SB) Company first introduced the 3 mg injection Kytri1 in South Africa. So far, including 1mg oral tablets, 1mg injections, granisetron hydrochloride has been listed in more than 40 countries and regions in the United States, Britain, France, Japan, Germany, Italy and so on. Smithkline-Beecham (SB) merged with Glaxo and transferred the product to Roche.

Foreign research data show that granisetron hydrochloride has a high degree of receptor selectivity. Its affinity for the 5-HT3 receptor is 4000-10000 times that of other receptors such as 5-HT1, 5-HT2, dopamine D1, D1, histamine H1, benzodiazepine, and opioid receptors. This difference in ondansetron is only 1000 times. In the prevention trial of cisplatin-induced vomiting, granisetron hydrochloride three dose groups: 2 x 0.005, 2 x 0.05, and 2 x 0.5 mg/kg (iv) had anti-emetic rates of 93%, 96%, and 100, respectively. %, while the antiemetic rate of ondansetron 2 x 2.5 mg/kg was 89%, indicating that granisetron hydrochloride has stronger antiemetic activity than ondansetron at least 5 times. Toxicity studies suggest that granisetron hydrochloride can achieve good anti-emetic effects at low doses with little side effects.

Applications:

It is a selective antagonist of serotonin 3 (5-HT3) in the peripheral and central nervous system. For nausea and vomiting caused by cytotoxic drugs or radiotherapy.
Antispasmodic drugs. Antiemetic drugs are used for nausea and vomiting caused by chemotherapy and radiotherapy.
Used as an antispasmodic

Usage And Synthesis

Outline of Granisetron hydrochloride Granisetron hydrochloride was originally developed by the British Beecham company in the mid-1980s. At 1991, the merged Smithkline-Beecham (SB) Company had pushed for the first time of 3 mg of injection Kytri1 to the market in South Africa. To date, including 1 mg of oral tablets, 1mg of injections, granisetron hydrochloride has already entered into market in United States, Britain, France, Japan, Germany, Italy and other more than forty countries and regions around the world. When the Smithkline-Beecham (SB) Company was merged with Glaxo Company, it transferred this product to the Roche Company.

Foreign research data has shown that granisetron hydrochloride has a high selectivity to receptor. Its affinity to 5-HT3 receptor is 4000 to 10000 time as high as its affinity to other receptors, such as 5-HT1, 5-HT2, dopamine D1, D1, histamine H1, benzodiazepine and opioid receptor. For comparison, the difference for ondansetron is only about 1,000 times. For the test of its prevention of cisplatin-induced emesis in ferrets, the antiemetic rates in the three dose groups of granisetron hydrochloride 2 × 0.005,2 × 0.05 and 2 × 0.5mg/kg (iv) were 93%, 96% and 100 %, respectively while for ondansetron in 2 × 2.5mg/kg, this value was 89%, demonstrating that granisetron hydrochloride exhibited a at least five times stronger efficacy of anti-emetic than ondansetron. Toxicity studies suggest that granisetron hydrochloride can achieve very excellent antiemetic effect even in small dose with only minor side effects. However, there may be sth abnormal occurring in cardiovascular system upon large doses. Since the recommended clinical dose of granisetron hydrochloride is small (3mg/d), which is only 1/25 (<1 mg/kg) of the lowest dose used in animal studies, therefore, clinical application of it is very safe. Pharmacokinetic study has shown that granisetron hydrochloride has a half-life (t1/2) of 9 h in the body of patient while this value is 4 h at healthy people, 7.7 h in elderly people and 4.9h in young people. Granisetron hydrochloride is mainly metabolized in the liver and can be excreted through the feces and urine in the form of 7-hydroxy granisetron hydrochloride and other forms of metabolic product. For patients of liver damage or liver metastases, they have reduced plasma clearance rate with the scavenging rate upon renal insufficiency being 1/4 of the normal case. It has been observed of high first pass metabolism upon oral administration with the absolute bioavailability being 60%.

Domestic Market Analysis 1993, China has approved of the import of the Kytri1 injection (3 mg/ 3 mL) of British SB company, Registration No: X930279, and has allowed for in clinical trials. In 1994, the China-US Tianjin Smith Kline Pharmaceutical Co., Ltd. had used imported raw materials processing method for production of the injection of the 3mg granisetron hydrochloride and had obtained the approval of the Ministry of Health: (94) health medicine approved: J-10 number (fourth class) with the trade name being “Kay Reiter. ” Currently there are a number of domestic manufacturers having their products enter into market with the number of manufacture which makes formulation being up to dozen, see Annex I for details.

China has a large population with the annual number of newly identified cancer patients being more than 1.6 million. The nausea and vomiting induced by chemotherapy and radiotherapy-induced have been one of the serious side effects that doctors and patients worry of. Therefore, new antiemetics are in urgent demand. Currently, ondansetron class of drugs has occupied most of the market antiemetic including ondansetron (ShufuLing), granisetron hydrochloride (Kytril) and tropisetron (Oubiting), wherein the ondansetron and granisetron has been accumulated of large number of clinical application experience with good response from the doctors and has played positive role on improving the domestic situation of the treatment of chemotherapy vomiting. With the localization of products, the decreasing price and the increasing income level of people, antiemetics market will be certainly greatly improved. In this case, granisetron hydrochloride, as the secondary antiemetic drug entering into market, will certainly have good market prospects.The above information is edited by the chemicalbook of Dai Xiongfeng.

Instructions [Character]it is colorless or nearly colorless liquid clarity.
[Toxicology]This product is a highly selective 5-HT3 receptor antagonist and has excellent preventive and therapeutic effect on treating nausea and vomiting induced by radiotherapy, chemotherapy and surgery. Radiotherapy, chemotherapy and surgery and other factors can cause enterochromaffin cells to release 5-HT; 5-HT can activate the 5-HT3 receptors in central nerve or vagus nerve and cause vomiting reflex. The mechanism of this product in controlling nausea and vomiting is through antagonizing the 5-HT3 receptor in the central chemosensory area and peripheral vagus nerve terminal, further suppressing the nausea and vomiting. This product has high selectivity and no side effects such as extrapyramidal reactions, excessive sedation and so on.Dosage and usage amount]intravenous drip. Recommended dosage for adults is usually 3 mg. Administer it intravenously 30 minutes prior to chemotherapy. Most patients only need to be administered once with the prevention action against nausea and vomiting being more than 24 hours. The number of doses can be increased by 1-2 times if necessary, but the maximum daily dose should not exceed 9 mg and the infusion time should not be less than 5 minutes.
[Pharmacokinetics]healthy volunteers, after intravenous injection of this product for 20 or 40 μg/kg, the average peak plasma concentration was 13.7 and 42.8μg/L, the plasma elimination half-life is approximately 3.1-5.9 hours. This product is widely distributed in the body with serum protein binding rate being about 65%. Most of them are rapidly metabolized with the major metabolic pathway being N-dealkylation and conjugation after aromatic oxidation. This product is excreted through the feces and urine.
Chemical Properties It is white or yellowish white crystalline powder and is odorless. It is easily soluble in water but hardly soluble in methanol, extremely hardly to be dissolved in ethanol and almost insoluble in ether. It has a melting point of 290-292 ℃. For acute toxicity LD50, female mice, male and female rats (mg/kg): 17, 25, 14, 16, respectively. Intravenous injection.
Uses It is the selective antagonist of the 5-serotonin 3 (5-HT3) in peripheral and central nervous system.

Uses A specific serotonin (5HT3) receptor antagonist. Used as an antiemetic. Granisetron HCl is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemothera py. Its main effect is to reduce the activity of the vagus nerve. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarini c receptor Biological Activity 5-HT 3 receptor antagonist that possesses potent antiemetic activity.

Our service

1.100% reshipment policy is our business basic.100% reshipment immediately if your parcel stays Customs for 4 days and doesn’t get updated.
2.Total refund for 15 days of dissatisfaction with quality.
3.We can provide free samples.
4.We have a special packing ,It can be easily passed through the customs.It will be more safe.
5.Our company have a long term cooperate with DHL.EMS.Fedex and so on .It can be sent to your hand more quickly. Parcel photo should be offered within 12hours after receiving your steroid payment.
6.If you have a chance to come to China. I can show you our lab.
7.Our company has WU, MG, TT, and Bitcoin payment ways in advance.You can pay 95% for the peptides cost at first for order, the rest can offer us in your next order;

Prohormone (Raw Powder)
Trenavar (Estra-4,9,11-triene-3,17-dione)
Methylstenbolone
Epistane (Methylepitiostanol)
Epiandrosterone acetate
Epiandrosterone
Hexadrone (6-chloro-androst-4-ene-3-one–17b-ol)
ATD (1,4,6-Androstatriene-3,17-dione)
6-Bro (6-Bromoandrostenedione)
DHEA ( Dehydroepiandrosterone)
1-DHEA (1-Androstene-3b-ol,17-one)
4-DHEA (4-Androstene-3b-ol,17-one)
7-keto DHEA
7-keto DHEA Acetate
4-Androstene-3,6,17-trione
Adrenosterone (androst-4-ene-3,11,17-trione)
Mebolazine (Dimethazine)
Halodrol (4-chloro-17a-methyl-androst-1,4-diene-3,17b-diol)
Methoxydienone
Androstenedione                     
Sex Enhancement (Raw Powder)
Sildenafil Citrate (Viagra)
Tadalafil (Cialis)
Dapoxetine
Dapoxetine HCL
Vardenafil
Vardenafil HCL
Yohimbine HCL
Avanafil
Flibanserin
Local Anesthetic (Raw Powder)
Benzocaine
Benzocaine HCL
Bupivacaine HCL
Bupivacaine 
Lidocaine
Lidocaine HCL
Pramoxine HCL
Prilocaine
Prilocaine HCL / Propitocaine HCL
Procaine
Procaine HCL(Novocain / Novocaine)
Procainamide hydrochloride
Ropivacaine HCL
Tetracaine
Tetracaine HCL
Mepivacaine
Mepivacaine hydrochloride
Trimecaine Hydrochloride
Dibucaine
Ropivacaine mesylate
Cinchocaine Hcl
Levobupivacaine
Ropivacaine hydrochloride
Dimethocaine Hydrochloride
Proparacaine hydrochloride
Dimethocaine Hydrochloride

Enquiry Form ( we will get back you as soon as possible )

Name:
*
Email:
*
Message:

Verification:
5 + 9 = ?

Maybe you like also

  • How to make order?

    Choose the items you wanna;
    Contact me via the email with your demand;
    Quote will be forwarded;
    Make the payment;
    Parcel arranged;
    Shippment arranged.
    Trace service will be provided.

  • Our Products

    Raw steroids powder

    SARMS

    Peptides

    Solvents

    APIS

    Filtering machine

    Tablets-press machine

    Vials, rubber, caps, cripmer

  • Shipment Servies

    EMS

    DHL

    Fedex

    TNT

    UPS

    EUB/ETK ect.

  • Contact Us

    Email:rawsteroidsale@gmail.com
    What's app:+8618676137192
    skype : +8618676137192
    Wedsite:http://www.powerfulsteroids.com/